EZH2 expression is a prognostic factor in childhood intracranial ependymoma: A Canadian Pediatric Brain Tumor Consortium study
Amanda M. Li(BC Children's Hospital), Juliette Hukin(BC Children's Hospital), Stephen Yip(University of British Columbia), Glenda Hendson(BC Children's Hospital), Lucie Lafay‐Cousin(Women & Children's Hospital of Buffalo), Shayna Zelcer(London Health Sciences Centre), Donna L. Johnston(Children's Hospital of Eastern Ontario), Anne‐Sophie Carret(Montreal Neurological Institute and Hospital), Christopher Dunham(BC Children's Hospital), Abbas Fotovati(Child and Family Research Institute), David D. Eisenstat(Royal Children's Hospital), Cynthia Hawkins(Hospital for Sick Children), Nada Jabado(McGill University), Sandra E. Dunn(Muscular Dystrophy UK), Mariana Silva(Kingston Health Sciences Centre), Christopher Fryer(BC Children's Hospital), P. Daniel McNeely(Izaak Walton Killam Health Centre), Uri Tabori(Universität Hamburg), Beverly Wilson(University of Alberta), Katrin Scheinemann(University of Lucerne)
Cited by 34
Related Papers
<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas
|New England Journal of Medicine|2010|1.7k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711